pI: 5.9644 |
Length (AA): 448 |
MW (Da): 51135 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
16 | 158 | 5cwm (A) | 90 | 227 | 14.00 | 0.15 | 0.09 | 0.502996 | -0.86 |
42 | 140 | 4qan (A) | 88 | 175 | 33.00 | 0.53 | 0.28 | 0.304082 | 0.97 |
78 | 168 | 5uh7 (A) | 66 | 152 | 32.00 | 0.63 | 0.97 | 0.654225 | -0.82 |
79 | 178 | 5szg (A) | 1867 | 1976 | 19.00 | 0 | 0.06 | 0.495214 | -1.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129228)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G28560 | protein shoot redifferentiation defective 2 |
Babesia bovis | BBOV_III010690 | hypothetical protein |
Brugia malayi | Bm1_46635 | hypothetical protein |
Caenorhabditis elegans | CELE_B0273.3 | Protein B0273.3 |
Caenorhabditis elegans | CELE_Y48G1BM.1 | Protein Y48G1BM.1 |
Caenorhabditis elegans | CELE_T02C12.2 | Protein T02C12.2 |
Cryptosporidium hominis | Chro.70130 | hypothetical protein |
Cryptosporidium parvum | cgd7_1050 | hypothetical protein |
Dictyostelium discoideum | DDB_G0274687 | hypothetical protein |
Drosophila melanogaster | Dmel_CG42515 | PSEA-binding protein 49kD |
Drosophila melanogaster | Dmel_CG42516 | CG42516 gene product from transcript CG42516-RB |
Echinococcus granulosus | EgrG_000128600 | expressed conserved protein |
Echinococcus granulosus | EgrG_000128500 | snRNA activating protein complex subunit 3 |
Entamoeba histolytica | EHI_197110 | snRNA activating protein complex subunit, putative |
Echinococcus multilocularis | EmuJ_000128500 | snRNA activating protein complex subunit 3 |
Echinococcus multilocularis | EmuJ_000128600 | expressed conserved protein |
Homo sapiens | 6619 | small nuclear RNA activating complex, polypeptide 3, 50kDa |
Leishmania braziliensis | LbrM.34.4640 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Leishmania donovani | LdBPK_354730.1 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Leishmania infantum | LinJ.35.4730 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Leishmania major | LmjF.35.4660 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Leishmania mexicana | LmxM.34.4660 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Loa Loa (eye worm) | LOAG_10462 | hypothetical protein |
Mus musculus | ENSMUSG00000028483 | small nuclear RNA activating complex, polypeptide 3 |
Oryza sativa | 4324317 | Os01g0912600 |
Plasmodium berghei | PBANKA_1324500 | snRNA-activating protein complex subunit 3, putative |
Plasmodium falciparum | PF3D7_1460800 | snRNA-activating protein complex subunit 3, putative |
Plasmodium knowlesi | PKNH_1220900 | snRNA-activating protein complex subunit 3, putative |
Plasmodium vivax | PVX_117415 | snRNA-activating protein complex subunit 3, putative |
Plasmodium yoelii | PY05165 | hypothetical protein |
Schistosoma japonicum | Sjp_0214600 | snRNA-activating protein complex subunit 3, putative |
Schistosoma mansoni | Smp_092780.1 | hypothetical protein |
Schistosoma mansoni | Smp_092780.2 | hypothetical protein |
Schmidtea mediterranea | mk4.010426.00 | snRNA-activating protein complex subunit 3 |
Trypanosoma brucei gambiense | Tbg972.9.5750 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Trypanosoma brucei | Tb927.9.9970 | Small nuclear RNA gene activation protein (SNAP) 50 |
Trypanosoma congolense | TcIL3000_9_3640 | small nuclear RNA gene activation protein 50 (EMBL:AJ581666) |
Trypanosoma cruzi | TcCLB.510731.50 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Trypanosoma cruzi | TcCLB.506887.60 | small nuclear RNA gene activation protein (SNAP) 50, putative |
Theileria parva | TP02_0077 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.1510 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1510 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1510 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.1510 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T02C12.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T02C12.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T02C12.2 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T02C12.2 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T02C12.2 | Caenorhabditis elegans | sterile | wormbase |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.